Robotic radical cystectomy with intracorporeal urinary diversion: beyond the initial experience.
Minimally-invasive surgery
bladder cancer
intracorporeal
urinary diversion
Journal
Translational andrology and urology
ISSN: 2223-4691
Titre abrégé: Transl Androl Urol
Pays: China
ID NLM: 101581119
Informations de publication
Date de publication:
Apr 2020
Apr 2020
Historique:
entrez:
19
5
2020
pubmed:
19
5
2020
medline:
19
5
2020
Statut:
ppublish
Résumé
Robotic assisted radical cystectomy (RARC) has gained popularity within minimally-invasive urologic surgery, and has been shown to be a safe procedure with similar oncologic outcomes when compared to the conventional open standard. While initial RARC feasibility and outcomes studies were performed with extracorporeal urinary diversion, intracorporeal urinary diversion (ICUD) is becoming increasingly utilized. Reported benefits of an intracorporeal approach include decreased blood loss and a lower incidence of ureteral strictures. While ICUD is technically challenging, many have overcome the learning curve associated with this procedure via a mentorship model and a dedicated operative team. Techniques vary between institutions, and ileal conduit, continent cutaneous and orthotopic continent (neobladder) diversions have all been performed. Herein, we describe the learning curve, technical points, and unique complications associated with ICUD.
Identifiants
pubmed: 32420210
doi: 10.21037/tau.2019.11.36
pii: tau-09-02-942
pmc: PMC7214984
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
942-948Informations de copyright
2020 Translational Andrology and Urology. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of Interest: The series “Robotic-assisted Urologic Surgery” was commissioned by the editorial office without any funding or sponsorship. The authors have no other conflicts of interest to declare.
Références
Eur Urol. 2016 Apr;69(4):704-709
pubmed: 26463317
Eur Urol. 2012 Nov;62(5):891-901
pubmed: 22920581
Asian J Urol. 2016 Jul;3(3):156-166
pubmed: 29264184
Eur Urol. 2014 Feb;65(2):340-7
pubmed: 24183419
BMJ Open. 2018 Aug 8;8(8):e020500
pubmed: 30093510
Urology. 2011 Apr;77(4):871-6
pubmed: 21256563
Eur Urol. 2011 Nov;60(5):1066-73
pubmed: 21852033
Urol Oncol. 2016 Jun;34(6):257.e1-9
pubmed: 26968561
Eur Urol. 2015 Oct;68(4):721-8
pubmed: 25985883
Eur Urol. 2018 Oct;74(4):465-471
pubmed: 29784190
Scand J Urol. 2016;50(2):95-103
pubmed: 26882458
J Robot Surg. 2020 Apr;14(2):261-269
pubmed: 31124038
Eur Urol. 2019 Apr;75(4):604-611
pubmed: 30337060
BJU Int. 2018 Apr;121(4):632-639
pubmed: 29124853
J Urol. 1982 Jul;128(1):34-6
pubmed: 7109065
J Urol. 2017 Aug;198(2):436-444
pubmed: 28336308
Clin Genitourin Cancer. 2015 Dec;13(6):562-7
pubmed: 26004301
World J Urol. 2020 Apr;38(4):837-843
pubmed: 31190152
BJU Int. 2018 Feb;121(2):313-317
pubmed: 29140596
BJU Int. 2014 Oct;114(4):617-29
pubmed: 24053179
Urology. 2020 Oct;144:225-229
pubmed: 29964128
Transl Androl Urol. 2018 Dec;7(Suppl 6):S735-S737
pubmed: 30687611
Urology. 2010 Oct;76(4):866-71
pubmed: 20451963
BJU Int. 2003 Aug;92(3):232-6
pubmed: 12887473
Eur Urol. 2003 Sep;44(3):337-9
pubmed: 12932932
Eur Urol. 2015 Mar;67(3):363-75
pubmed: 25582930
J Urol. 2013 Feb;189(2):541-7
pubmed: 23260561
Urology. 2014 Apr;83(4):824-9
pubmed: 24680450
J Urol. 2014 Dec;192(6):1734-40
pubmed: 25016136
Int Urol Nephrol. 2019 May;51(5):765-771
pubmed: 30903392
Eur Urol. 2016 Apr;69(4):613-621
pubmed: 26272237
Eur Urol. 2015 Mar;67(3):423-31
pubmed: 25595099
Eur Urol. 2012 Sep;62(3):431-52
pubmed: 22749853
Urol Oncol. 2013 Aug;31(6):871-7
pubmed: 21906965
J Urol. 2018 May;199(5):1302-1311
pubmed: 29275112
BJU Int. 2014 Jan;113(1):100-7
pubmed: 24053710
J Endourol. 2017 Dec;31(12):1269-1276
pubmed: 28967280
Lancet. 2018 Jun 23;391(10139):2525-2536
pubmed: 29976469
Eur Urol. 2010 Aug;58(2):197-202
pubmed: 20434830
Eur Urol Focus. 2017 Apr;3(2-3):273-279
pubmed: 28753745
J Urol. 2011 Feb;185(2):562-7
pubmed: 21168867
Eur Urol. 2013 Apr;63(4):637-43
pubmed: 23265384